thalidomide has been researched along with Leukemia, Pre-B-Cell in 4 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arribas, I | 1 |
| Maluquer, C | 1 |
| Pomares, H | 1 |
| Carro, I | 1 |
| Baca, C | 1 |
| Bosch, A | 1 |
| Arévalo, CE | 1 |
| Montané, C | 1 |
| Ribes-Amorós, J | 1 |
| Zamora, L | 1 |
| Granada, I | 1 |
| Gamundi, E | 1 |
| Arnan, M | 1 |
| Sureda, A | 1 |
| Sinit, RB | 1 |
| Hwang, DG | 1 |
| Vishnu, P | 1 |
| Peterson, JF | 1 |
| Aboulafia, DM | 1 |
| Vundamati, D | 1 |
| Bostrom, B | 1 |
| Liu, D | 1 |
| Chen, S | 1 |
| Pan, J | 1 |
| Zhu, M | 1 |
| Wu, N | 1 |
| Zhu, F | 1 |
| Chen, Z | 1 |
2 reviews available for thalidomide and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature.
Topics: Humans; Lenalidomide; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Thalidomide | 2023 |
B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Bone Marrow; Humans; Immunologic Factors; Lenalidomide; | 2019 |
2 other studies available for thalidomide and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
Prolonged Response in Patient With Multiply Relapsed B-cell Acute Lymphoblastic Leukemia and Monosomy-7 to Bortezomib, Lenalidomide, and Dexamethasone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Child; Chromosome Deletion; Chromosomes, | 2016 |
Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient.
Topics: Adult; Anemia, Macrocytic; Blood Transfusion; Bone Marrow; Cell Differentiation; Cell Lineage; Chrom | 2012 |